You are here

New drug shows promise in repairing failing hearts

New drug shows promise in repairing failing hearts A new experimental drug has shown promise in restoring cardiac function after heart failure, according to results of an early human trial. The researchers found that an infusion of the drug cimaglermin was generally tolerated except for transient nausea and headache. “These findings support continued clinical development of the investigational drug cimaglermin, including further safety evaluations and detailing the potential improvement on clinical heart failure outcome measures,” said lead author of the study Daniel Lenihan from Vanderbilt University in Nashville, Tennessee, US….

Read More

Laser therapy with deep-sea drug kills prostate cancer cells

A non-surgical treatment for lowrisk prostate cancer, in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient’s bloodstream, was shown in a trial to kill cancer cells without destroying healthy tissue. Results of a trial in 413 patients showed that the drug, which is activated with a laser to destroy tumour tissue in the prostate, was so effective that half the patients went into remission, compared with 13.5% in a control group.”These results are excellent news for men with early localised prostate cancer, offering a treatment…

Read More

Breakthrough malaria drug likely by ’18

Breakthrough malaria drug likely by ’18 (Getty Images) Contrary to the perception that drug research is mostly focused around the diseases of the elite, the antimalarial drug pipeline has increased nearly three-fold since 2008, with at least three new medicines expected to be launched in two to five years. India, where a lot of clinical trials have already begun, is likely to get a breakthrough anti-malarial drug Tafenoquine by 2018. The drug, a one-day-two-dose treatment, has already entered phase-three trials and once approved will replace the current 14-day treatment for…

Read More

Wilson’s disease drug goes off the shelves

Wilson’s disease drug goes off the shelves A life-saving medicine D-Penicillamine, used in treatment of Wilson’s disease, is unavailable across the country, jeopardising lives of many patients. The shortage, primarily caused because of short supply of raw material used in the drug, prompted the drug regulator to call for an urgent meeting on Friday with five manufacturers of the drug. Wilson’s disease is a rare genetic disorder that prevents the body from getting rid of extra copper. The accumulation of copper may damage liver, brain, kidneys and eyes. D-Penicillamine is…

Read More

Common Diabetes Drug May Cut Weight in Autistic Kids

A drug commonly used as the front-line treatment for Type-2 diabetes may also be effective in reducing weight in children and adolescents with autism spectrum disorder (ASD), finds a study. ASD is a serious developmental disorder that impairs the ability to communicate and interact. Individuals suffering from autism spectrum disorder take atypical antipsychotics drugs to treat symptoms of irritability and agitation. These drugs often increases their appetite as well as weight, thus raising a long-term risk of diabetes. The study explored the effectiveness of metformin drug in counteracting weight gain…

Read More

meals And Drug management(FDA) Approves device That Drains food out of your belly

The most sudden issue about the meals and Drug management’s approval of the weight problems-control device called AspireAssist may be how little mainstream interest it attracted. due to the fact, frankly, a 391f28ade68635a26d417ea25e9ae9c1 gadget that helps you to devour all you want and then drains the food out of your belly is a pretty startling invention.AspireAssist works like this: In a fifteen-minute outpatient method, a general practitioner implants a tube into a patient’s belly. The tube is attached to a valve that lies flush towards the skin of the abdomen….

Read More